LAPTM4B Alleviates Pulmonary Fibrosis by Enhancing NEDD4L-Mediated TGF-β Signaling Suppression
Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease involves a complex interplay of cell types and signaling pathways (1). With a median survival time of only 3-5 years from diagnosis, IPF carries a prognosis worse than …